Welcome to Alzeim
Alzeim Ltd. is at the forefront in the production of sustainable quantities of naturally derived Galanthamine.
This natural alkaloid is a key active pharmaceutical ingredient registered and approved for the treatment of Alzheimer’s disease.
Alzeim’s unique research into the production of natural Galanthamine allows the company to fill a significant need in the pharmaceutical market that ultimately benefits those who are suffering from Alzheimer’s disease.
Alzeim's work on the production of Galanthamine from daffodils grown in Wales was featured in the BBC's Countryfile program that was broadcast on Sunday 24th April 2011. If you have not seen the feature then please click here to view the video.